HFM Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$598 Buy
14
+12
+600% +$652 ﹤0.01% 931
2026
Q1
$126 Sell
2
-15
-88% -$1.2K ﹤0.01% 1091
2025
Q4
$1.62K Buy
17
+2
+13% +$196 ﹤0.01% 336
2025
Q3
$1.46K Buy
15
+1
+7% +$104 ﹤0.01% 250
2025
Q2
$1.5K Buy
14
+7
+100% +$708 ﹤0.01% 240
2025
Q1
$707 Buy
+7
New +$705 ﹤0.01% 211

Other funds holding BSX

HFM Investment Advisors's BSX Position: Q2 2026 in Review

HFM Investment Advisors increased its Boston Scientific (BSX) stake by 600% in Q2 2026, buying an estimated $652 and bringing the position to 14 shares worth $598. The position accounts for ﹤0.01% of the portfolio, ranked #931.

HFM Investment Advisors first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.62K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HFM Investment Advisors held 14 shares of Boston Scientific worth $598 as of Q2 2026.
  • HFM Investment Advisors bought 12 Boston Scientific shares in Q2 2026, an estimated $652.
  • Boston Scientific made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #931 holding.
  • HFM Investment Advisors first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's Boston Scientific position peaked at $1.62K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.